OncoXome
1 known investors
Oncoxome develops an oral delivery platform for cancer therapies that targets tumor cells directly with minimal off-target toxicity. The platform enables delivery of various therapeutic modalities including CRISPR, siRNA, mRNA, and proteins to cancer patients.
BiotechDeep TechMedical Devices
Investors · 1
In the news
- Form D OncoXome, Inc.streetinsider.com · 2023
- OncoXome is charging ahead with gene therapy to treat resistant cancersbio.news · 2022